Pharma BD Deal Intelligence

Boehringer Ingelheim Pharmaceuticals / J&J/Pfizer (US OTC Zantac rights)

2006 · Asset Purchase · $510M · Complete

OTC H-2 blocker rights divested per FTC order; $509.5M cash

Key facts

• Announced Dec 12, 2006
• Deal value $510M
• Deal type Asset Purchase

← Browse all deals  ·  How we score deals